Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCLnow 19# (hUC-MSC) in Heart Failure
NCT03180450Phase 2Suspended
- Sponsor
- Sclnow Biotechnology Co., Ltd.
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in heart failure (HF) (2 arms), sponsored by Sclnow Biotechnology Co., Ltd. Primary endpoint: Heart color ultrasound evaluation (Left Ventricular Ejection Fraction) at 12 months. Started Dec 2025; status: suspended.
02
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03180450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180450.